EP is a community where members connect through shared life experiences-- like MS--and so much more. You are not defined by any one thing, so be your true self and find others just like you at
Experience Project.
Posted: Tue May 20, 2008 4:42 pm Post subject: Dabur Pharma gets USFDA approval for selling Mitoxantrone
Dabur Pharma Ltd's oncology unit has informed that the company has received the approval from US Food and Drug Administrator (USFDA) for selling 'Mitoxantrone Hydrochloride in various strengths’.
Dabur Pharma Ltd operates in Europe and other overseas markets through its fully-owned subsidiary, Dabur Oncology Plc.
The drug is indicated for reducing neurologic disability and /or the frequency of clinical relapses in patients with secondary chronic progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis (i.e., patients whose neurologic status is significantly abnormal between relapses).
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum